| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |